Acotec Scientific Holdings Limited

SEHK:6669 Rapporto sulle azioni

Cap. di mercato: HK$2.4b

Acotec Scientific Holdings Crescita futura

Future criteri di controllo 5/6

Acotec Scientific Holdings is forecast to grow earnings and revenue by 68% and 21.2% per annum respectively while EPS is expected to grow by 65.7% per annum.

Informazioni chiave

68.0%

Tasso di crescita degli utili

65.7%

Tasso di crescita dell'EPS

Medical Equipment crescita degli utili39.2%
Tasso di crescita dei ricavi21.2%
Rendimento futuro del capitale proprion/a
Copertura analitica

Low

Ultimo aggiornamento29 Oct 2024

Aggiornamenti recenti sulla crescita futura

Recent updates

An Intrinsic Calculation For Acotec Scientific Holdings Limited (HKG:6669) Suggests It's 46% Undervalued

Mar 21
An Intrinsic Calculation For Acotec Scientific Holdings Limited (HKG:6669) Suggests It's 46% Undervalued

We Think Acotec Scientific Holdings (HKG:6669) Can Easily Afford To Drive Business Growth

Nov 17
We Think Acotec Scientific Holdings (HKG:6669) Can Easily Afford To Drive Business Growth

Acotec Scientific Holdings Limited's (HKG:6669) Intrinsic Value Is Potentially 42% Above Its Share Price

Oct 20
Acotec Scientific Holdings Limited's (HKG:6669) Intrinsic Value Is Potentially 42% Above Its Share Price

Acotec Scientific Holdings (HKG:6669) Has More To Do To Multiply In Value Going Forward

Sep 24
Acotec Scientific Holdings (HKG:6669) Has More To Do To Multiply In Value Going Forward

An Intrinsic Calculation For Acotec Scientific Holdings Limited (HKG:6669) Suggests It's 49% Undervalued

Jul 01
An Intrinsic Calculation For Acotec Scientific Holdings Limited (HKG:6669) Suggests It's 49% Undervalued

Previsioni di crescita degli utili e dei ricavi

SEHK:6669 - Stime future degli analisti e dati finanziari passati (CNY Millions )
DataRicaviGuadagniFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
12/31/2025712114N/A871
12/31/202457181N/A651
6/30/202452332-6727N/A
3/31/202449823-807N/A
12/31/202347414-93-13N/A
9/30/202346938-85-18N/A
6/30/202346361-77-22N/A
3/31/202342966-96-45N/A
12/31/202239670-115-69N/A
9/30/202236717-105-68N/A
6/30/2022339-35-96-68N/A
3/31/2022338-24-61-35N/A
12/31/2021304-79-32-10N/A
9/30/2021285-76-30-7N/A
6/30/2021266-74-28-4N/A
3/31/2021228-81-22-1N/A
12/31/2020194-44-27-9N/A
12/31/2019125231720N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: 6669's forecast earnings growth (68% per year) is above the savings rate (2.3%).

Guadagni vs Mercato: 6669's earnings (68% per year) are forecast to grow faster than the Hong Kong market (11.5% per year).

Guadagni ad alta crescita: 6669's earnings are expected to grow significantly over the next 3 years.

Ricavi vs Mercato: 6669's revenue (21.2% per year) is forecast to grow faster than the Hong Kong market (7.7% per year).

Ricavi ad alta crescita: 6669's revenue (21.2% per year) is forecast to grow faster than 20% per year.


Previsioni di crescita dell'utile per azione


Rendimento futuro del capitale proprio

ROE futuro: Insufficient data to determine if 6669's Return on Equity is forecast to be high in 3 years time


Scoprire le aziende in crescita